A comparison of the effect of carbomer-, cellulose-, and mineral oil-based artificial tear formulations

European Journal of Ophthalmology

Volumn 17, Issue 2, 2007, Pages 151-159

  Wang, I Jong ^a   Lin, I C ^a   Hou, Y C ^a   Hu, F R ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Carbomer based artificial tears; Cellulose based artificial tears; Keratoconjunctivitis sicca; Mineral oil based artificial tears

Indexed keywords

ARTIFICIAL TEAR; CARBOMER; CELLULOSE; CETRIMIDE; MINERAL OIL; SORBITOL;

ADULT; AGED; ARTICLE; BLURRED VISION; BURNING SENSATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG FORMULATION; DRY EYE; EYELID DISEASE; FEMALE; HUMAN; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; STICKY EYELID; SYMPTOMATOLOGY; TREATMENT RESPONSE;

EID: 34250346940     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700202     Document Type: Article

References (19)

1. Lemp MA. Epidemiology and classification of dry eye. Adv Exp Med Biol 1998; 438: 791-803.
2. Dohlman CH, Lemp MA, English FP. Dry eye syndromes. Int Ophthalmol Clin 1970; 10: 215-51.
3. Bach FC, Adam JB, McWhirter HC, Johnson JE. Ocular retention of artificial tear solutions. Comparison of hydroxypropyl methylcellulose and polyvinyl alcohol vehicles using an argyrol marker. Ann Ophthalmol 1972; 4: 116-9.
4. Holly FJ. Artificial tear formulations. Int Ophthalmol Clin 1980; 20: 171-84.
5. Leibowitz HM, Chang RK, Mandell AI. Gel tears. A new medication for the treatment of dry eyes. Ophthalmology 1984; 91: 1199-204.
6. Swanson M. Compliance with and typical usage of artificial tears in dry eye conditions. J Am Optom Assoc 1998; 69: 649-55.
7. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995; 21: 221-32.
8. Jones LT. The lacrimal secretory system and its treatment. Am J Ophthalmol 1966; 62: 47-60.
9. Murube J, Nemeth J, Hoh H, et al. The triple classification of dry eye for practical clinical use. Eur J Ophthalmol 2005; 15: 660-7.
10. Beunckens C, Molenberghs G, Kenward MG. Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials. Clin Trials 2005; 2: 379-86.
11. Friedlaender MH. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca. Rheum Dis Clin North Am 1992; 18: 591-608.
12. Nelson JD, Farris RL. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca. Arch Ophthalmol 1988; 106: 484-7.
13. Sullivan LJ, McCurrach F, Lee S, et al. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome. Ophthalmology 1997; 104: 1402-8.
14. Marquardt R, Christ T. [Corneal contact time of artifi-cial tear solutions.] Klin Monatsbl Augenheilkd 1986; 189: 254-7.
15. Marner K, Mooller PM, Dillon M, Rask-Pedersen E. Viscous carbomer eye drops in patients with dry eyes. Efficacy and safety. A randomized, open, cross-over, multicentre study. Acta Ophthalmol Scand 1996; 74: 249-52.
16. Brodwall J, Alme G, Gedde-Dahl S, et al. A comparative study of polyacrylic acid (Viscotears) liquid gel versus polyvinylalcohol in the treatment of dry eyes. Acta Ophthalmol Scand 1997; 75: 457-61.
17. Toda I, Shinozaki N, Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea 1996; 15: 120-8.
18. Diebold Y, Herreras JM, Callejo S, Argueso P, Calonge M. Carbomer-versus cellulose-based artificial-tear formulations: morphologic and toxicologic effects on a corneal cell line. Cornea 1998; 17: 433-40.
19. Marquardt R, Christ T, Bonfils P. [Gelatinous tear substitutes and nonspecific eye ointments in the critical care unit and in perioperative use.] Anaesth Intensivther Notfallmed 1987; 22: 235-8.